Core Viewpoint - The company, Jiuan Medical, has successfully launched its respiratory virus triple detection product for consumer sales and is expanding its market presence through various online and offline channels [1] Group 1 - The respiratory virus triple detection product is now in regular sales on the consumer end, covering platforms such as Amazon, CVS, and Walmart [1] - The company is nearing the end of clinical trials for its quadruple detection product, which tests for influenza A, influenza B, COVID-19, and respiratory syncytial virus [1] - The company aims to accelerate patient recruitment to expedite the product launch, leveraging the high incidence of respiratory diseases during the winter season [1]